AP Biology class blog for discussing current research in Biology

Author: branchiolon

The Network to Longer Life


A recent collaborative study between scientists at the Buck Institute for Research on Aging, the MDI Biological Laboratory, and the Nanjing University in China found an interesting synergetic pathway between the IIS (insulin signaling pathway) and TOR pathway by studying C.elegans: nematodes that share many genes with human beings.

The short lifespan of C.elegans (three to four weeks) allowed the scientists to identify the cellular pathways that regulated aging. The scientists were able to genetically change the IIS and TOR pathways by using a double mutant on the C.elegans. The alterations were expected to yield a 130% increase in the lifespan of the C.elegans, since altering the IIS pathway yields a 100% increase and altering the TOR pathway yields a 30% increase. However, the math didn’t work out, and that’s a good thing! Surprisingly, the lifespan of the C.elegans increased by 500%.

So, even though the scientists discovered the pathways that regulated aging in C.elegans, the nuances of these interactions are still unclear. A paper discussing this topic relates longevity to the mitochondria’s role in maintaining homeostasis.  Jarod A. Rollins, one of the authors of the paper, hopes to further clarify and investigate the role of mitochondria on aging in his future research.

Even still, the discover of these cellular pathways could lead to longer lives for humans. Pathways such as these were passed down to humans by evolution (conserved) so, the 500% increase in longevity that occurred in C.elegans after alteration could also occur in humans. Although the way in which these pathways affect each other is unclear, we now know that multiple genes and cellular pathways contribute to the aging process.

How do you think that the IIS and TOR pathways affect each other? If our lifespans are expanded in the future, what will be the moral and societal implications?


Don’t Kill Me Immune System! I’m a Friend.

Believe it or not, but not all bacteria is out to get you, especially some of your gut bacteria. These helpful bacteria can aid in digestion and overall healthy, but the question is, why doesn’t your immune system kill them just like harmful bacteria? In other words, how does the immune system differentiate between good and bad bacteria? For now, we are not really sure, but a study from March of this year by Immunologist Ivaylo Ivanov and his team at Columbia University could bring us closer to understanding this form of cell signaling.

The study focuses particularly on the interaction between T cells and segmented filamentous bacteria in the gut. Normally, the immune system would produce antibodies that would bind to antigens on the foreign cell’s surface. As a result, the cell would be marked for destruction by the immune system. However, through an experiment on mice, the researchers found that although the T cells were activated by the segmented filamentous bacteria, the T cells did not destroy the bacteria.

These gut bacteria located in human, mouse, and fish intestines cling themselves to the gut wall and have antigens. So why aren’t they killed? Well, the antigens are packaged in tiny vesicles located near the tip of the hook-like appendage that the bacteria uses to cling to the gut wall: the holdfast. Sorry, that’s about all I can give you. The rest is speculation at this point.

Nonetheless, Ivanov and his team discovered something previously unnoticed by finding these vesicles that hold antigens in segmented filamentous bacteria. They speculate that the T cells read antigens in different ways based on whether or not it’s exposed on the outside of the cell or packaged in a vesicle. In the end, this a big discovery that peaks my interest, especially for its implications on the study of cell signaling. What’s your hypothesis as to why the T cells don’t attack the gut bacteria?

The Oxygen Sensing Discovery: A Huge Impact on Cancer Research

On October 7, 2019, three scientists- William G. Kaelin, Gregg L. Semenza, and Peter J. Ratcliffe- won the 2019 Nobel Peace Prize in Physiology or Medicine for their groundbreaking discovery in the 1990’s of how cells detect and respond to the presence of oxygen. That may not seem very significant-even Ratcliffe’s colleague’s dimissed his facination with how organs respond to oxygen availability-but the applications are profound. In fact, the Nobel prize was not awarded until recently for this very reason: to evaluate the “when the full impact of the discovery has become evident” (Ralf Pettersson, a former Nobel Selection comittee chairman). Well, their research has provided an possible explaination for the rapid metastasis for which cancer cells are notorious.

According to Ratcliffe’s research, cells produce a complex of proteins called the hypoxia-inducible factor, HIF, that help increase the level of oxygen when cells are oxygen deficient. The HIF turns on genes necessary for the production of the hormone erythropoietin, EPO. In turn, the EPO protein hormone signals for red blood cells to be produced in the bone marrow. Through oxygen-carrying hemoglobin, the red blood cells carry more oxygen to tissues and cells. For example, when the body undergoes hypoxia in response to lack of oxygen, like when people occupy high altitudes, HIF turns on production of EPO.

However, when the oxygen levels are sufficient in the cell, proteins called ubiquitin will bind to the HIF and induce it’s destruction. In this way, cells sense when oxygen levels are low or high and can respond accordingly by regulating the presence of HIF.

That’s pretty cool right? It gets better.

Through the individual work of Semenza and Kaelin, cancer cells were discovered to sense oxygen levels by manipulating VHL. While conducting their separate research, both Semenza and Kaelin hypothesized that cancer cells were searching for oxygen when they spread. Kaelin, as a cancer biologist, took specific interest in von Hippel-Lindau disease, a rare hereditary disease in which either malign or benign tumors form in mostly in the nervous system, pancreas, adrenal glands, and kidneys. The VHL protein, which the VHL gene codes for, in humans helps prevents tumor formation by recognition of the indicator hydroxyl groups placed on HIF by enzymes when the oxygen level are normal. In this case, VHL knows to destroy HIF. On the other hand, if the oxygen levels are low, the HIF lack the hydroxyl groups and are ignored by VHL. During research, he discovered that in these type of cancers, the VHL genes are mutated so that VHL becomes inactive. As a result, it can no longer regulate the quantity of HIF proteins thus, the HIF level increases. Increased HIF levels mean more oxygen for cancer cell, which multiply rapidly because of their now readily available supply of oxygen. This knowledge is vital since Harvard cell biologist Andrew Murray say that “tumors can grow to only about 1 millimeter across without making new blood vessels, because oxygen can diffuse only about half a millimeter away from a capillary before cells consume it”.

The trio’s research is fascinating to me, because this knowledge could be revolutionary in preventing the development and spread of cancer cells. What other biological issue do you think that the discovery of oxygen sensing could solve?



Powered by WordPress & Theme by Anders Norén

Skip to toolbar